Veterinary Medicine Information website

Versican Plus P lyophilisate and solvent for suspension for injection for dogs

Not authorised
  • Canine parvovirus, type 2b, strain CPV-2b Bio 12/B, Live
Download as PDF

Product identification

Medicine name:
Versican Plus P lyophilisate and solvent for suspension for injection for dogs
Active substance:
  • Canine parvovirus, type 2b, strain CPV-2b Bio 12/B, Live
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine parvovirus, type 2b, strain CPV-2b Bio 12/B, Live
    3981070.00
    50% tissue culture infectious dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AD01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Bulgaria
Package description:
  • (ID2): 1 Box with (1 Vial (Glass) with 50 Dose and 1 Vial (Glass) with 50 Dose) (50.0 Dose, 50.0 Dose)
  • (ID1): 1 Box with (1 Vial (Glass) with 25 Dose and 1 Vial (Glass) with 25 Dose) (25.0 Dose, 25.0 Dose)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Bulgarian Agency For Food Safety
Authorisation number:
  • 0022-2631
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0265/001

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 9/03/2022
Download